Literature DB >> 15669681

Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease.

U H Schueler1, T Kolter, C R Kaneski, G C Zirzow, K Sandhoff, R O Brady.   

Abstract

Gaucher disease, the most common sphingolipidosis, is caused by a decreased activity of glucosylceramide beta-glucosidase, resulting in the accumulation of glucosylceramide in macrophage-derived cells known as Gaucher cells. Much of the storage material is thought to originate from the turnover of cell membranes, such as phagocytosed red and white blood cells. In this study, an in vitro model of Gaucher disease was developed by treating the murine macrophage cell line J774 with a specific inhibitor of glucosylceramide beta-glucosidase, conduritol B-epoxide, and feeding red blood cell ghosts, in order to mimic the disease state. It was found in this model system that glucosylceramide beta-glucosidase activity could be reduced to about 11-15% of the normal control level before increased storage of glucosylceramide occurred. This in vitro system allows insight into the correlation between enzyme activity and lipid storage as predicted by the theory of residual enzyme activity that was proposed by Conzelmann and Sandhoff.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15669681     DOI: 10.1023/b:boli.0000042959.44318.7c

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  33 in total

1.  METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE.

Authors:  R O BRADY; J N KANFER; D SHAPIRO
Journal:  Biochem Biophys Res Commun       Date:  1965-01-18       Impact factor: 3.575

2.  Analysis of the lipids of normal and Gaucher bone marrow.

Authors:  S P Miller; G C Zirzow; S H Doppelt; R O Brady; N W Barton
Journal:  J Lab Clin Med       Date:  1996-04

3.  Altered ganglioside biosynthesis in mouse cell cultures following transformation with chemical carcinogens and x-irradiation.

Authors:  P L Coleman; P H Fishman; R O Brady; G J Todaro
Journal:  J Biol Chem       Date:  1975-01-10       Impact factor: 5.157

4.  The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects.

Authors:  M C Stephens; A Bernatsky; V Burachinsky; G Legler; J N Kanfer
Journal:  J Neurochem       Date:  1978-05       Impact factor: 5.372

5.  Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.

Authors:  T Cox; R Lachmann; C Hollak; J Aerts; S van Weely; M Hrebícek; F Platt; T Butters; R Dwek; C Moyses; I Gow; D Elstein; A Zimran
Journal:  Lancet       Date:  2000-04-29       Impact factor: 79.321

6.  Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells.

Authors:  D S Newburg; T B Shea; S Yatziv; S S Raghavan; R H McCluer
Journal:  Exp Mol Pathol       Date:  1988-06       Impact factor: 3.362

7.  The Gaucher mouse: additional biochemical alterations.

Authors:  M C Stephens; A Bernatsky; G Legler; J N Kanfer
Journal:  J Neurochem       Date:  1979-03       Impact factor: 5.372

8.  Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition.

Authors:  S Yatziv; D S Newburg; N Livni; G Barfi; E H Kolodny
Journal:  J Lab Clin Med       Date:  1988-04

9.  Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators.

Authors:  G Wilkening; T Linke; K Sandhoff
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

View more
  40 in total

1.  A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transfer.

Authors:  Lakshya Bajaj; Jaiprakash Sharma; Alberto di Ronza; Pengcheng Zhang; Aiden Eblimit; Rituraj Pal; Dany Roman; John R Collette; Clarissa Booth; Kevin T Chang; Richard N Sifers; Sung Y Jung; Jill M Weimer; Rui Chen; Randy W Schekman; Marco Sardiello
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  MALDI imaging of lipid biochemistry in tissues by mass spectrometry.

Authors:  Karin A Zemski Berry; Joseph A Hankin; Robert M Barkley; Jeffrey M Spraggins; Richard M Caprioli; Robert C Murphy
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

3.  Inhibition of endoplasmic reticulum-associated degradation rescues native folding in loss of function protein misfolding diseases.

Authors:  Fan Wang; Wensi Song; Giovanna Brancati; Laura Segatori
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

4.  The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms.

Authors:  Richard A Steet; Stephen Chung; Brandon Wustman; Allan Powe; Hung Do; Stuart A Kornfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

5.  Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention.

Authors:  Zhanqian Yu; Anu R Sawkar; Lisa J Whalen; Chi-Huey Wong; Jeffery W Kelly
Journal:  J Med Chem       Date:  2007-01-11       Impact factor: 7.446

Review 6.  Enzyme replacement therapy and beyond-in memoriam Roscoe O. Brady, M.D. (1923-2016).

Authors:  Markus Ries
Journal:  J Inherit Metab Dis       Date:  2017-03-17       Impact factor: 4.982

7.  FKBP10 depletion enhances glucocerebrosidase proteostasis in Gaucher disease fibroblasts.

Authors:  Derrick Sek Tong Ong; Ya-Juan Wang; Yun Lei Tan; John R Yates; Ting-Wei Mu; Jeffery W Kelly
Journal:  Chem Biol       Date:  2013-02-21

8.  ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's disease.

Authors:  Yun Lei Tan; Joseph C Genereux; Sandra Pankow; Johannes M F G Aerts; John R Yates; Jeffery W Kelly
Journal:  Chem Biol       Date:  2014-08-14

9.  Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis.

Authors:  Derrick Sek Tong Ong; Ting-Wei Mu; Amy E Palmer; Jeffery W Kelly
Journal:  Nat Chem Biol       Date:  2010-05-09       Impact factor: 15.040

10.  Structural snapshots illustrate the catalytic cycle of β-galactocerebrosidase, the defective enzyme in Krabbe disease.

Authors:  Chris H Hill; Stephen C Graham; Randy J Read; Janet E Deane
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.